¥¹¥Ý¥ó¥µ¡¼¥µ¥¤¥È

¾åµ­¤Î¹­¹ð¤Ï£±¥ö·î°Ê¾å¹¹¿·¤Î¤Ê¤¤¥Ö¥í¥°¤Ëɽ¼¨¤µ¤ì¤Æ¤¤¤Þ¤¹¡£¿·¤·¤¤µ­»ö¤ò½ñ¤¯»ö¤Ç¹­¹ð¤¬¾Ã¤»¤Þ¤¹¡£

[ --/--/-- --:-- ] ¥¹¥Ý¥ó¥µ¡¼¹­¹ð | TB(-) | CM(-)

ç¹´â¿ÇÎÅ¥¬¥¤¥É¥é¥¤¥ó 2009ǯÈÇ 1

¡Ö²Ê³ØÅªº¬µò¤Ë´ð¤Å¤¯ç¹´â¿ÇÎÅ¥¬¥¤¥É¥é¥¤¥ó 2009ǯÈǡפȡÖç¹´â¼è°·¤¤µ¬Ìó 2009¡×¤¬È¯´©¤µ¤ì¤Þ¤·¤¿¡£

Êѹ¹ÅÀ¤Ï

1¡¥Âè1ÈǤκîÀ®Ã´ÅöÊìÂΤ¬ÆüËÜç¹Â¡³Ø²ñç¹´â¿ÇÎÅ¥¬¥¤¥É¥é¥¤¥óºîÀ®¾®°Ñ°÷²ñ¤Ç¤¢¤Ã¤¿¤¬¡¢º£²ó¤ÏÆüËÜç¹Â¡³Ø²ñç¹´â¿ÇÎÅ¥¬¥¤¥É¥é¥¤¥ó²þÄû°Ñ°÷²ñ¤È¤Ê¤Ã¤¿¡£
2¡¥ºÇ¿·¤Î¥¨¥Ó¥Ç¥ó¥¹Äɲäϡ¢Âè1ÈǽÐÈǸå¤Î¿·¤·¤¤¥¨¥Ó¥Ç¥ó¥¹¤Î·ÏÅýŪ¸¡º÷¤ò¹Ô¤¤¡¢¤µ¤é¤Ë¸½ºß¤ÎÆüËܤμÂÎ×¾²¤ò´ª°Æ¤·¤Æ¿ä¾©Ê¸¤òºîÀ®¤·¤¿¡£

CQ1-1 ¡¡ç¹´â¤Î´í¸±°ø»Ò¤Ï²¿¤«¡©

1. ´í¸±°ø»Ò¤òÊ£¿ôÍ­¤¹¤ë¾ì¹ç¤Ï¡¢ç¹´â¸¡½Ð¤Î¤¿¤á¤Î¸¡ºº¤ò¹Ô¤¦¤è¤¦´«¤á¤é¤ì¤ë¡£¥°¥ì¡¼¥ÉB

2. ç¹´ÉÆâÆýƬǴ±ÕÀ­¼ðáç¡¡(IPMN)¤Ï´â¤Ø¿ÊŸ¤¹¤ë¤³¤È¤äç¹´â¤ò¹çÊ»¤¹¤ë¤³¤È¤¬¤¢¤ë¤Î¤Ç¡¢Åª³Î¤Ê¿ÇÃǤȿµ½Å¤Ê·Ð²á´Ñ»¡¤¬´«¤á¤é¤ì¤ë¡£¥°¥ì¡¼¥ÉB

ç¹´â´µ¼Ô¤Î4-8%¤Ï²È²Îò¤Ë繴⤢¤ë¡£¡ÊÂоȷ²¤ËÈæ¤Ù13ÇܤȹâΨ¡Ë

°äÅÁÀ­ç¹±ê¡¢²È²À­²È²Á£¼ð¥Ý¥ê¥Ý¡¼¥·¥¹¡¢Peutz-Jeghers¾É¸õ·²¡¢familial multiple mole melanoma¾É¸õ·²¡¢²È²À­Æý¤¬¤ó¤Ê¤É¤Î°äÅÁÀ­¼À´µ¤Ç¤Ïç¹´âȯÀ¸Î¨¤¬¹â¤¤

ç¹´â´µ¼Ô¤Î´û±ýÎò¤Ç¤ÏÅüǢɤ¬25.9¡ó¤ÈºÇ¤âÉÑÅÙ¤¬¹â¤¤¡£ËÜË®¤Ç¤ÏÅüÇ¢ÉÂÎò¤Î¤¢¤ë´µ¼Ô¤Ç´í¸±Î¨¤Ï1.85ÇÜ¡£¡Ê¿¤¯¤ÎÊó¹ð¤Ç¤Ï¤ª¤ª¤è¤½1.8-2.1ÇܤǤ¢¤ë¡Ë

ÈîËþ¤ä²áÂνŤÏç¹´â´í¸±Î¨¤òÁý²Ã¤µ¤»¤ë¡£BMJ30°Ê¾å¤Ç¤Ï1.8ÇÜ

ËýÀ­ç¹±ê¤Îç¹´âȯÀ¸¤ÎÁêÂÐŪ´í¸±ÅÙ¤Ï4-8ÇÜ¡£

IPMN 0.95-1.1%/ǯ

µÊ±ì¤Ïç¹´â¤Î´í¸±Î¨¤ò2-3ÇܤËÁý²Ã¤µ¤»¤ë¡£ÃËÀ­¤Ç¤Ï¶Ø±ì¤Ë¤è¤êç¹´â¤Î22¡ó¤ÏͽËɤǤ­¤ë¡£

CQ1-2 ç¹´â¤ÎÎ×¾²¾É¾õ¤Ï²¿¤«¡©

1. ¾¤Ë¸¶°ø¤Î¤ß¤é¤ì¤Ê¤¤Ê¢ÄË¡¢¹øÇØÉôÄË¡¢²«áÕ¡¢ÂνŸº¾¯¤Ïç¹´â¤òµ¿¤¤¸¡ºº¤ò¹Ô¤¦¤¬¡Ê¥°¥ì¡¼¥ÉB¡Ë¡¢Í­¾É¾õ¤Î¾ì¹ç¤Ï¿Ê¹Ô´â¤¬Â¿¤¤¡£¡¡

2. µÞ·ã¤ÊÅüǢɡÊÅüÂå¼Õ¾ã³²¡Ë¤Îȯ¾É¤ä°­²½¤Ïç¹´â¹çÊ»¤òµ¿¤¤¡¢¸¡ºº¤ò¹Ô¤¦¡Ê¥°¥ì¡¼¥ÉB¡Ë¡£ÆÃ¤ËÅüÇ¢ÉÂȯ¾É¸å3ǯ¤ÏÃí°Õ¤òÍפ¹¤ë¡£¡¡

ƬÉô´â¤Ç¾É¾õ¤Îȯ¸½Î¨¤¬ºÇ¤â¹â¤¯¡¢²«áÕ63%, Ê¢ÄË64%,¡¡ÂνŸº¾¯53%

ÂÎÉô´â¤Ç¤ÏÊ¢Äˤ¬93¡ó¤ÈºÇ¤â¹â¤¤¡£¡¡

ç¹´â´µ¼Ô187Îã¤Î¸¡Æ¤¤ÇÀè¹Ô2ǯ°ÊÆâ¤ÎÅüÇ¢ÉÂȯ¾É¤¬52.5%¤È¹â¤¤¡£

50ºÐ°Ê¾å¤ÎÅüǢɽéȯ´µ¼Ô2122̾¤ÎÌó1¡ó¤¬3ǯ°ßÆâ¤Ëç¹´â¤ò¹çÊ»¡£¡¡

55ºÐ°Ê¾å¤ÎÅüǢɽéȯ·²¤Ç¡¢·ìÅü¡¢·ìÃæç¹¹ÚÁÇ¡¢¼ðáç¥Þ¡¼¥«¡¼¡¢US½ê¸«¤Ç¤¤¤º¤ì¤«¤Î°Û¾ï¤òǧ¤á¤¿»þÅÀ¤ÇÆâ»ë¶ÀŪµÕ¹ÔÀ­ç¹´É¤±Æ¤ò¹Ô¤Ã¤¿½ê¡¢13.9%¤¬ç¹´â¤È¿ÇÃÇ¡£

CQ1-3¡¡ç¹´â¤òµ¿¤Ã¤¿¾ì¹ç¡¢¤Þ¤º¹Ô¤¦¤Ù¤­¸¡ºº¤Ï²¿¤«¡©¡¡

1. ·ìÃæç¹¹ÚÁǤÏç¹¼À´µ¿ÇÃǤ˽ÅÍפÀ¤¬¡¢ç¹´â¤ËÆÃ°ÛŪ¤Ç¤Ï¤Ê¤¤¡£¥°¥ì¡¼¥ÉC1

2. CA19-9¤ò´Þ¤à¼ðáç¥Þ¡¼¥«¡¼Â¬Äê¤Ïç¹´â¿ÇÃǤäç¹´â¥Õ¥©¥í¡¼¥¢¥Ã¥×¤Ë´«¤á¤é¤ì¤ë¡Ê¥°¥ì¡¼¥ÉB¡Ë¤¬¡¢Áá´üç¹´â¤Î¸¡½Ð¤Ë¤ÏÍ­ÍѤǤϤʤ¤¡£¥°¥ì¡¼¥ÉC1

3. US¤Ïç¹´â¤ÎºÇ½é¤Î¥¹¥¯¥ê¡¼¥Ë¥ó¥°¤Ë´«¤á¤é¤ì¤ë¡Ê¥°¥ì¡¼¥É£Â¡Ë¤¬¡¢¸¡¿Ç¤Ç¤Î¸¡½ÐΨ¤ÏÄ㤤¡Ê¥°¥ì¡¼¥ÉC1¡Ë¡£¼ç繴ɤγÈÄ¥¤äǹ˦¤¬ç¹´â¤Î´ÖÀܽ긫¤È¤·¤Æ½ÅÍפǤ¢¤ë¡£¡Ê¥°¥ì¡¼¥ÉB¡Ë¡£¤³¤Î¤è¤¦¤Ê½ê¸«¤¬¤ß¤È¤á¤é¤ì¤¿¾ì¹ç¤Ï¡¢¤¹¤ß¤ä¤«¤ËCT¸¡ºº¤ò¤Ï¤¸¤á¤È¤¹¤ë¸¡ºº¤ò¹Ô¤¦¤³¤È¤¬¶¯¤¯´«¤á¤é¤ì¤ë¡£¡Ê¥°¥ì¡¼¥ÉA¡Ë

4. ¾åµ­¸¡ºº¤Ç°Û¾ï½ê¸«¤¬Ç§¤á¤é¤ì¤ë¤âç¹´â¤Î³ÎÄê¿ÇÃǤ˻ê¤é¤Ê¤¤¾ì¹ç¤Ë¤Ï¡¢°Ê¸å¤ÎÄê´üŪ¤Ê¸¡ºº¤È¿µ½Å¤Ê·Ð²á´Ñ»¡¤¬´«¤á¤é¤ì¤ë¡£¥°¥ì¡¼¥ÉB

Ä̾ï¤Î¿¦¾ì¸¡¿Ç¤Ç¤ÎUS¤Ë¤è¤ëç¹²èÁü¤ÎÍ­½ê¸«Î¨¤ÏÌó1%¤Ç¡¢ç¹´âȯ¸«Î¨¤ÏÌó0.06%°Ê²¼¤ÈÄ㤤¡£

CA19-9 70-80%, Span-1 70-80% Dupan-2 50-60%, CEA 30-60%, CA50 60%

繴⸡½Ð¤Ë¤Ä¤Ê¤¬¤ë´ÖÀܽ긫¤È¤·¤Æ¡¢¼ç繴ɤγÈÄ¥¡Ê2mm°Ê²¼¡Ë¤äǹ˦¤¬ç¹´â¤ÎÁ°¶î½ê¸«¡Ê¥ì¥Ù¥ë­·¡Ë¤¬¹Í¤¨¤é¤ì¡¢¤³¤Î¤è¤¦¤Ê½ê¸«¤¬¤ß¤é¤ì¤¿¾ì¹ç¤Ï¡¢Â®¤ä¤«¤ËCT¸¡ºº¤ò¤Ï¤¸¤á¤È¤¹¤ë¼¡¤Î¥¹¥Æ¥Ã¥×¤Ø¿ÇÃǤò¿Ê¤á¤ë¤Ù¤­¤Ç¤¢¤ë¡£

CQ1-4 ç¹´â¤òµ¿¤Ã¤¿¾ì¹ç¡¢¼¡¤Ë¹Ô¤¦¤Ù¤­¸¡ºº¤Ï²¿¤«¡©

£±¡¥ ç¹´â¤Î¼£ÎÅÊý¿Ë·èÄê¤Î¤¿¤á¤Ë¤Ï¼ÁŪ¿ÇÃǤ¬É¬¿Ü¤Ç¡¢¹Ô¤¦¤è¤¦¶¯¤¯´«¤á¤é¤ì¤ë¡£¥°¥ì¡¼¥ÉA

£²¡¥ ç¹´â¤ÏUSµÚ¤ÓCT¡Ê¤±Æ¤¬Ë¾¤Þ¤·¤¤¡Ë¤ò¹Ô¤¤¡¢É¬Íפ˱þ¤¸¤ÆMRCP, EUS, ERP, PET¤òÁȤ߹ç¤ï¤»¤ë¤è¤¦¶¯¤¯´«¤á¤é¤ì¤ë¡£¥°¥ì¡¼¥ÉA

¡¦2cm°Ê²¼¤ÎÉÂÊѤǤÏÊ¢ÉôͲ»ÇȤǴ¶ÅÙ57%, ñ½ãCT¤Ç50%¡£Â¤±ÆCT¤Ç70%Á°¸å¡£

¤½¤Î¾¤Î¸¡ºº¤È¤·¤Æ

¡¦MRCP¤Ï´¶ÅÙ95¡ó¡¢ÆÃ°ÛÅÙ82%¡¡Àµ¾ï¤Êç¹´ÉÁü¤òÄ褹¤ëç¹´â¤Ï3¡ó̤Ëþ¡£

¡¦EUS¤Ï´¶ÅÙ86-100%,¡¡ÆÃ°ÛÅÙ58.3-97%

¡¦PET¤Ï´¶ÅÙ82-95%(2cm°Ê²¼¤Ç¤Ï68.8¡ó)

CQ1-5 ç¹´â¤Ë¤ª¤±¤ëºÙ˦¿Ç¡¢ÁÈ¿¥¿Ç¤ÎŬ±þ¤È°ÕµÁ¤Ï¡©

1. ³Æ¼ï¤Î²èÁü¸¡ºº¤Ë¤è¤êç¹¼ðáî¤Î¼ÁŪ¿ÇÃǤ¬¤Ä¤«¤Ê¤¤¾ÉÎã¤Ç¤Ï¡¢¼£Îų«»Ï¤Ë¤¢¤¿¤êÁÈ¿¥¤â¤·¤¯¤ÏºÙ˦¿Ç¤Ë¤è¤ë³ÎÄê¿ÇÃǤ¬Ë¾¤Þ¤·¤¤¡£³ÎÄê¿ÇÃÇË¡¤È¤·¤ÆÄ¶²»ÇÈ¥¬¥¤¥É²¼Àü»ÉµÛ°úºÙ˦¿Ç¡¦ÁÈ¿¥¿Ç¡¢ERCP²¼ç¹±ÕºÙ˦¿Ç¡¢ERCP²¼ÁÈ¿¥¿Ç¤Ê¤É¤¬¤¢¤ê¡¢´µ¼Ô¤È»ÜÀߤξõ¶·¤«¤éŬÀÚ¤ÊÊýË¡¤òÍѤ¤¤ë¡£¥°¥ì¡¼¥ÉB

2. Ͳ»ÇÈÆâ»ë¶À²¼Àü»ÉµÛ°úºÙ˦¿Ç¤ÏÊ¢ÉôͲ»Çȸ¡ºº¤äCT¤Ê¤É¤Ç¼ðáî¤òª¤¨¤ë¤³¤È¤¬º¤Æñ¤ÊÉÂÊѤËÂФ·¤Æ¤âÍ­ÍѤǤ¢¤ë¡£¥°¥ì¡¼¥ÉC1

3. °äÅÁ»Ò¸¡º÷¤ÏºÙ˦¿Ç¡¦ÁÈ¿¥¿Ç¤ÎÊä½õŪ¿ÇÃǤȤ·¤ÆÍ­ÍѤǤ¢¤ë¡£¥°¥ì¡¼¥ÉC1



²Ê³ØÅªº¬µò¤Ë´ð¤Å¤¯ç¹´â¿ÇÎÅ¥¬¥¤¥É¥é¥¤¥ó 2009ǯÈDzʳØÅªº¬µò¤Ë´ð¤Å¤¯ç¹´â¿ÇÎÅ¥¬¥¤¥É¥é¥¤¥ó 2009ǯÈÇ
(2009/10)

ç¹´â¼è°·¤¤µ¬Ìóç¹´â¼è°·¤¤µ¬Ìó
(2009/07)
ÆüËÜç¹Â¡³Ø²ñ





[ 2009/12/25 11:06 ] ç¹Â¡¡¡¤¹¤¤Â¡´â | TB(0) | CM(0)
¥³¥á¥ó¥È¤ÎÅê¹Æ












´ÉÍý¼Ô¤Ë¤À¤±É½¼¨¤òµö²Ä¤¹¤ë
¥È¥é¥Ã¥¯¥Ð¥Ã¥¯
¤³¤Îµ­»ö¤Î¥È¥é¥Ã¥¯¥Ð¥Ã¥¯URL
http://amylase.blog121.fc2.com/tb.php/846-8c854463




ºÇ¶á¤Îµ­»ö¡Ü¥³¥á¥ó¥È
BBS

Twitter Updates

    follow me on Twitter